Results 51 to 60 of about 1,968,036 (106)

Etiopathogenesis of Immune‐Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 5, May 2026.
This review systematically clarifies that the core of IMNM begins with specific autoantibodies, which in turn trigger complement activation, immune cell infiltration, and a storm of inflammatory factors. Together, these processes induce regulatory cell death and mitochondrial dysfunction, ultimately leading to muscle fiber necrosis. Genetic factors and
Chang Gao   +4 more
wiley   +1 more source

Risk Factors for Recurrence of the Anti‐Synthetase Syndrome Related Interstitial Lung Disease

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 4, April 2026.
ABSTRACT Purpose This current study aimed to detect the risk factors for recurrence of the anti‐synthetase syndrome related interstitial lung disease (ASSD‐ILD). Methods Patients who were diagnosed with ASSD‐ILD and achieved the improving standards after treatment at a single clinical center from January 1, 2017 to January 1, 2022 were retrospectively ...
Zhen‐Yu Ren   +4 more
wiley   +1 more source

MOESM1 of Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

open access: yes, 2020
Additional file 1 : Table S1.
Baptiste Hervier (7069286)   +33 more
core   +1 more source

Myasthenia gravis following the initiation of statin therapy: A multinational self‐controlled case series study

open access: yesJournal of Internal Medicine, Volume 299, Issue 4, Page 502-514, April 2026.
Abstract Background Evidence regarding the risk of new‐onset myasthenia gravis (MG) following statin therapy initiation is limited. Objectives To investigate this potential adverse effect using multinational real‐world population‐based data. Methods A self‐controlled case series (SCCS) study was conducted using electronic medical records and claims ...
Vincent Ka Chun Yan   +16 more
wiley   +1 more source

PROTAC‑Mediated HMGCR Depletion Reprograms Lipid Metabolism in Breast Cancer to Potentiate Photoimmunotherapy via Ferroptosis

open access: yesAdvanced Science, Volume 13, Issue 13, 3 March 2026.
This work introduces a study that identifies HMGCR as a novel target in TNBC and develops a light‐gated PROTAC nanomedicine. Upon irradiation, this agent selectively degrades HMGCR, reprogramming lipid metabolism to induce ferroptosis and potent antitumor immunity, thereby significantly enhancing photoimmunotherapy efficacy.
Tong Su   +18 more
wiley   +1 more source

Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy

open access: yes
. Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level.
Cavusoglu, Dilek   +3 more
core   +1 more source

Laboratory tests and clinical significance of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibody

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2016
Anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) antibody is a newly recognized autoantibody, which is associated with the use of statins and is considered as an immunological marker of necrotizing autoimmune myopathy (NAM).
Jing-jing LUO   +5 more
doaj  

Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report

open access: yes, 2021
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) related myositis is a form of immune-mediated necrotizing myopathy (IMNM). Anti-HMGCR autoantibodies target HMGCR, a glycoprotein linked to the endoplasmic reticulum implied in the cholesterol ...
Ali G.   +4 more
core   +1 more source

Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy

open access: yesArthritis Research & Therapy
Objective Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) autoantibodies are one of the myositis-specific antibodies which is associated with immune-mediated necrotizing myopathy (IMNM).
Hongxia Yang   +7 more
doaj   +1 more source

MOESM4 of Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

open access: yes, 2020
Additional file 4 : Table S4.
Baptiste Hervier (7069286)   +33 more
core   +1 more source

Home - About - Disclaimer - Privacy